MAP1LC3A Antikörper
Kurzübersicht für MAP1LC3A Antikörper (ABIN7268517)
Target
Alle MAP1LC3A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- MAP1LC3A Rabbit mAb
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Monoclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- A synthesized peptide derived from human MAP1LC3A
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000, IHC,1:50 - 1:200,IP,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
-
Andere Bezeichnung
- MAP1LC3A
-
Hintergrund
- MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. The expression of variant 1 is suppressed in many tumor cell lines, suggesting that may be involved in carcinogenesis. [provided by RefSeq, Feb 2012],ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3,Autophagy,Autophagy_ATGs,Cancer,Cardiovascular,Cell Biology & Developmental Biology,Cytoskeleton,Cytoskeleton_Microtubules,Endocrine & Metabolism,Heart,Mitochondrial metabolism,MAP1LC3A
-
Molekulargewicht
- 16kDa
-
Gen-ID
- 84557
-
UniProt
- Q9H492
-
Pathways
- Autophagie
Target
-